AAAAAA

   
Results: 1-17 |
Results: 17

Authors: CHABOT GG ARMAND JP TERRET C DEFORNI M ABIGERGES D WINOGRAD B IGWEMEZIE L SCHACTER L KAUL S ROPERS J BONNAY M
Citation: Gg. Chabot et al., ETOPOSIDE BIOAVAILABILITY AFTER ORAL-ADMINISTRATION OF THE PRODRUG ETOPOSIDE PHOSPHATE IN CANCER-PATIENTS DURING A PHASE-I STUDY, Journal of clinical oncology, 14(7), 1996, pp. 2020-2030

Authors: WIBAULT P BENSMAINE MEA DEFORNI M ARMAND JP BERNAL ET GUILLOT T RECONDO G DOMENGE C JANOT F BOREL C LUBOINSKI B ESCHWEGE F CVITKOVIC E
Citation: P. Wibault et al., INTENSIVE CONCOMITANT CHEMORADIOTHERAPY IN LOCALLY ADVANCED UNRESECTABLE SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK - A PHASE-II STUDY OFRADIOTHERAPY WITH CISPLATIN AND 7-WEEK CONTINUOUS INFUSIONAL FLUOROURACIL, Journal of clinical oncology, 14(4), 1996, pp. 1192-1200

Authors: ARMAND JP DUCREUX M MAHJOUBI M ABIGERGES D BUGAT R CHABOT G HERAIT P DEFORNI M ROUGIER P
Citation: Jp. Armand et al., CPT-II (IRINOTECAN) IN THE TREATMENT OF COLORECTAL-CANCER, European journal of cancer, 31A(7-8), 1995, pp. 1283-1287

Authors: MARTY M KLEISBAUER JP FOURNEL P VERGNENEGRE A CARLES P LORIAKANZA Y SIMONETTA C DEBRUIJN KM LAURAINE P DIDIER A CUPISSOL D BERGERAT JP PUJAZON MC HERON JF DRENO B TAYTARD A GUERIN JC CLAVIER J ROBINET G BLANCHON F BALMES P MUIR JF PAILLOTIN D POIRIER R BONNETERRE J MELLONI B ROCHE H DEPIERRE A PLAGNE R SOUQUET PJ ARMAND JP DEFORNI M
Citation: M. Marty et al., IS NAVOBAN(R) (TROPISETRON) AS EFFECTIVE AS ZOFRAN(R) (ONDANSETRON) IN CISPLATIN-INDUCED EMESIS, Anti-cancer drugs, 6, 1995, pp. 15-21

Authors: DEFORNI M CHABOT GG ARMAND JP GOUYETTE A KLINKALAK M RECONDO G
Citation: M. Deforni et al., PHASE-I AND PHARMACOLOGY STUDY OF FLAVONE ACETIC-ACID ADMINISTERED 2 OR 3 TIMES WEEKLY WITHOUT ALKALINIZATION, Cancer chemotherapy and pharmacology, 35(3), 1995, pp. 219-224

Authors: LEMAIRE L MALETMARTINO MC MARTINO R DEFORNI M LASSERRE B
Citation: L. Lemaire et al., THE TRIS FORMULATION OF FLUOROURACIL IS MORE CARDIOTOXIC THAN THE SODIUM-SALT FORMULATIONS, Oncology Reports, 1(1), 1994, pp. 173-174

Authors: CHATELUT E ROSTAING L GUALANO V VISSAC T DEFORNI M TONTHAT H SUC JM HOUIN G CANAL P
Citation: E. Chatelut et al., PHARMACOKINETICS OF CARBOPLATIN IN A PATIENT SUFFERING FROM ADVANCED OVARIAN-CARCINOMA WITH HEMODIALYSIS-DEPENDENT PENAL INSUFFICIENCY, Nephron, 66(2), 1994, pp. 157-161

Authors: DEFORNI M BUGAT R CHABOT GG CULINE S EXTRA JM GOUYETTE A MADELAINE I MARTY ME MATHIEUBOUE A
Citation: M. Deforni et al., PHASE-I AND PHARMACOKINETIC STUDY OF THE CAMPTOTHECIN DERIVATIVE IRINOTECAN, ADMINISTERED ON A WEEKLY SCHEDULE IN CANCER-PATIENTS, Cancer research, 54(16), 1994, pp. 4347-4354

Authors: LEMAIRE L ARELLANO M MALETMARTINO MC MARTINO R DEFORNI M
Citation: L. Lemaire et al., 5-FLUOROURACIL CARDIOTOXICITY - A QUESTIO N OF FORMULATION, Bulletin du cancer, 81(12), 1994, pp. 1057-1059

Authors: DEFORNI M CHABOT GG ARMAND JP FONTANA X RECONDO G DOMENGE C CARDE P BARBU M GOUYETTE A
Citation: M. Deforni et al., PHASE-I AND PHARMACOKINETIC STUDY OF BREQUINAR (DUP-785 NSC-368390) IN CANCER-PATIENTS, European journal of cancer, 29A(7), 1993, pp. 983-988

Authors: MULLER C CHATELUT E GUALANO V DEFORNI M HUGUET F ATTAL M CANAL P LAURENT G
Citation: C. Muller et al., CELLULAR PHARMACOKINETICS OF DOXORUBICIN IN PATIENTS WITH CHRONIC LYMPHOCYTIC-LEUKEMIA - COMPARISON OF BOLUS ADMINISTRATION AND CONTINUOUS-INFUSION, Cancer chemotherapy and pharmacology, 32(5), 1993, pp. 379-384

Authors: CODY R STEWART D DEFORNI M MOORE M DALLAIRE B AZARNIA N GYVES J
Citation: R. Cody et al., MULTICENTER PHASE-II STUDY OF BREQUINAR SODIUM IN PATIENTS WITH ADVANCED BREAST-CANCER, American journal of clinical oncology, 16(6), 1993, pp. 526-528

Authors: ARMAND JP CVITKOVIC E RECONDO G WIBAULT P SCHWAAB G DOMENGE C TELLEZBERNAL E GANDIA D LUBOINSKI B ESCHWEGE F DEFORNI M
Citation: Jp. Armand et al., SALVAGE CHEMOTHERAPY IN RECURRENT HEAD AND NECK-CANCER - THE INSTITUT-GUSTAVE-ROUSSY EXPERIENCE, American journal of otolaryngology, 14(5), 1993, pp. 301-306

Authors: NGUYEN T DEFORNI M ARMAND JP GUEGUEN M AVRIL MF
Citation: T. Nguyen et al., COMPLETE REMISSION OF A SQUAMOUS-CELL CAR CINOMA TREATED WITH THE ASSOCIATION OF INTERFERON-ALPHA 2A AND ISOTRETINOIN AFTER FAILURE OF CONVENTIONAL THERAPIES, Annales de dermatologie et de venereologie, 120(11), 1993, pp. 827-829

Authors: BACHAUD JM DAVID JM SHUBINSKI RE PERINEAU D BOUSSIN G SERRANO E DEFORNI M PESSEY JJ DALYSCHVEITZER NJ
Citation: Jm. Bachaud et al., PREDICTIVE FACTORS OF A COMPLETE RESPONSE TO AND ADVERSE-EFFECTS OF ACDDP-5FU COMBINATION AS PRIMARY THERAPY FOR HEAD AND NECK SQUAMOUS CARCINOMAS, Journal of Laryngology and Otology, 107(10), 1993, pp. 924-930

Authors: DEFORNI M GUALANO V CANAL P MARTEL P IZARSOUM F CHEVREAU C SOULIE P ROCHE H BUGAT R
Citation: M. Deforni et al., CONTINUOUS-INFUSION OF 5-FLUOROURACIL BY DOUBLE ROUTE (INTRAVENOUS AND INTRAPERITONEAL) WITH MODULATION BY FOLINIC ACID - CLINICAL AND PHARMACOKINETIC, PHASE-I STUDY IN PATIENTS WITH INTRAABDOMINAL MALIGNANCIES, Bulletin du cancer, 80(5), 1993, pp. 408-417

Authors: DEFORNI M BONEU A OTAL P MARTEL P SHUBINSKI R BUGAT R LUCOT H
Citation: M. Deforni et al., ANATOMIC CHANGES IN THE ABDOMINAL-CAVITY DURING INTRAPERITONEAL CHEMOTHERAPY - PROSPECTIVE-STUDY USING SCINTIGRAPHIC PERITONEOGRAPHY, Bulletin du cancer, 80(4), 1993, pp. 345-350
Risultati: 1-17 |